Harvard Bioscience Inc
HBIO· Nasdaq
HBIOHarvard Bioscience Inc
Released Nov 5, 2020, before the open
10-Q filed Nov 6, 2020, 37 days after period end · 0001171843-20-007747
| Metric | Q3 2020 | Q3 2019 | Q3 2018 | Q3 2017 |
|---|---|---|---|---|
| Revenue | $24.04M | $27.42M | $28.64M | $18.72M |
| Net Income | -$1.10M | -$2.62M | -$256.00K | -$417.00K |
| EPS Diluted |
Harvard Bioscience Inc · CIK 1123494 · Engraved from SEC EDGAR
| -$0.03 |
| -$0.07 |
| -$0.01 |
| -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
